The use of caffeine as a metabolic probe for human drug metabolizing enzymes.
about
Cytochrome P450 isoform selectivity in human hepatic theobromine metabolismRepresentative Sinusoids for Hepatic Four-Scale Pharmacokinetics SimulationsSummary of information on human CYP enzymes: human P450 metabolism data.Effects of the antifungal agents on oxidative drug metabolism: clinical relevance.Coffee consumption, genetic susceptibility and bladder cancer risk.Genetics of caffeine consumption and responses to caffeine.Assessment of drug-drug interactions: concepts and approaches.The differential effect of NAT2 variant alleles permits refinement in phenotype inference and identifies a very slow acetylation genotypeCaffeine's Vascular Mechanisms of ActionArylamine N-acetyltransferases and drug response.In vitro evaluation of potential in vivo probes for human flavin-containing monooxygenase (FMO): metabolism of benzydamine and caffeine by FMO and P450 isoformsCaffeine affects the biological responses of human hematopoietic cells of myeloid lineage via downregulation of the mTOR pathway and xanthine oxidase activity.Review article: The prevalence and clinical relevance of cytochrome P450 polymorphisms.Xanthine Oxidoreductase in Drug Metabolism: Beyond a Role as a Detoxifying Enzyme.Chemical inhibitors of cytochrome P450 isoforms in human liver microsomes: a re-evaluation of P450 isoform selectivity.Cardiovascular complications from consumption of high energy drinks: recent evidence.In vitro-in vivo extrapolation of zolpidem as a perpetrator of metabolic interactions involving CYP3A.Does hepatic metabolism of melatonin affect the endogenous serum melatonin level in man?Identification and fragmentation pathways of caffeine metabolites in urine samples via liquid chromatography with positive electrospray ionization coupled to a hybrid quadrupole linear ion trap (LTQ) and Fourier transform ion cyclotron resonance masCytochrome P450 mRNA expression in peripheral blood lymphocytes as a predictor of enzyme induction.Scientific Opinion on the safety of caffeineScientific Opinion on Flavouring Group Evaluation 49, Revision 1 (FGE.49Rev1): xanthine alkaloids from the priority listPharmacokinetic and pharmacodynamic interactions between zolpidem and caffeine.Evaluation on activity of cytochrome p450 enzymes in turbot via a probe drug cocktail.Determination of urine caffeine and its metabolites by use of high-performance liquid chromatography-tandem mass spectrometry: estimating dietary caffeine exposure and metabolic phenotyping in population studies.Comparison ofN-Acetyltransferase-2 Enzyme Genotype-Phenotype and Xanthine Oxidase Enzyme Activity Between Swedes and KoreansN-acetyltransferase-2 (NAT2) Gene Polymorphisms and Enzyme Activity in Serbs: Unprecedented High Prevalence of Rapid Acetylators in a White Population
P2860
Q24564968-F3DF5061-AC51-4E73-BB0A-DEB943D03B0BQ28546872-C22F24F4-0B15-4899-9F37-92836FAEB423Q32103802-D8D93BEB-0BDF-40F6-BABE-619D70B98B8EQ33858325-6BED21AC-D3DD-45DC-9CC2-110E25E090F3Q34031319-797CB4E6-B387-4C81-93A6-DDF41C45AC54Q34119748-69914DEE-3110-4F2C-BB80-A13721029A08Q34378923-17585FCB-DAC1-4BD0-9CB5-B045DA00A2D9Q34412637-33EC428F-9FC4-47E4-A65F-E5F4931EE48FQ34415153-77A77786-9F18-411D-AA1A-C7B73692E37EQ34673370-1D8C9E66-B99F-4D96-BA4C-4A103134C50BQ36055300-A17AB285-4386-400A-93A1-C9E658F4133BQ36557120-E5D5B4F0-B74E-4623-A2B3-4FA2B9BC7902Q37032772-A68ECD47-3616-462C-8D3E-5DF52C8BE54CQ37692717-293F81F1-E328-4C08-A611-B50DAAD52FE5Q37845170-82378C4D-9F56-4768-B33D-B4A9DD6888CBQ38221384-74022678-1756-4697-A74B-BB5BE8025D8DQ43220404-F9AB061B-CD77-47C4-A3D3-7415C12DEE8BQ44009657-3BC2C888-297F-47DB-9BA9-02F2A48EF723Q46101173-68BC68B1-6B45-48BD-8A26-F407D58DE864Q46616703-1FFCB15C-A963-4074-9C7D-A9DAC7F4D7A4Q47156955-4EF92848-1A13-456C-8423-539769E8D80AQ47159207-36E6B81B-46AC-450C-A20A-8ED94ECAA30BQ48471344-67C941DF-4EC7-43D6-828B-FF8050BD3D1AQ52781877-DF57BEB3-9297-42E0-8638-5E97A4447B11Q54489147-8D7EFA33-0D6F-4259-B8E8-06300988DB1AQ58003090-003F125D-A6E2-47F5-801B-19B3F01BC42BQ58003100-C676A2D7-6164-426A-932F-75A697950B8E
P2860
The use of caffeine as a metabolic probe for human drug metabolizing enzymes.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh
1996年學術文章
@zh-hant
name
The use of caffeine as a metabolic probe for human drug metabolizing enzymes.
@en
type
label
The use of caffeine as a metabolic probe for human drug metabolizing enzymes.
@en
prefLabel
The use of caffeine as a metabolic probe for human drug metabolizing enzymes.
@en
P1433
P1476
The use of caffeine as a metabolic probe for human drug metabolizing enzymes.
@en
P2093
P304
P356
10.1016/0306-3623(95)02014-4
P577
1996-03-01T00:00:00Z